Markus Hoffmann
Has grant
Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Markus Hoffmann is a Professor at the University of Lübeck in Germany. His research focuses on inflammatory skin diseases, autoimmune blistering diseases, and therapeutic strategies for inflammatory rheumatic diseases. Recent publications include works on tissue priming in arthritis and the role of spermidine in autophagy and longevity, highlighting his contributions to the understanding of immune regulation and inflammatory pathways.
Recent Grants
Grant: Close
Metabolic and dietary control of inflammatory tissue priming and arthritis
Open Date: 2022-04-01
Close Date: 2025-03-01
Grant: Close
Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation (NeutroCure).
Open Date: 2020-01-01
Close Date: 2025-01-01
Grant: Close
Amplification of NET Formation and Neutrophil Aggregation for the Resolution of Inflammation
Open Date: 2019-07-01
Close Date: 2023-07-01
Grant: Close
Immunometabolic Checkpoints within Synovial Fibroblasts in Rheumatoid Arthritis
Open Date: 2019-04-01
Close Date: 2022-03-01
Grant: Close
The importance of Neutrophil extracellular traps for the resolution of neutrophil-driven inflammation
Open Date: 2015-07-01
Close Date: 2019-06-01
Articles (19)
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Clodronate liposomes (Clo-Lip) have been widely used to deplete mononuclear phagocytes (MoPh) to study the function of these cells in vivo. Here, we revisited the effects of Clo-Lip together with genetic models of MoPh deficiency, revealing that Clo-Lip exert their anti-inflammatory effects independent of MoPh. Notably, not only MoPh but also polymorphonuclear neutrophils (PMN) ingested Clo-Lip in vivo, which resulted in their functional arrest. Adoptive transfer of PMN, but not of MoPh, reversed the anti-inflammatory effects of Clo-Lip treatment, indicating that stunning of PMN rather than depletion of MoPh accounts for the anti-inflammatory effects of Clo-Lip in vivo. Our data highlight the need for a critical revision of the current literature on the role of MoPh in inflammation.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (18)
Simon Sedej
Associate Professor
Medical University of Graz
Christoph Becker
-
Claudio De Virgilio
Full Professor
University of Fribourg
Ulrike Steffen
-
Gerhard Krönke
-
Caroline Ospelt
University of Zurich
Mahmoud Abdellatif
Tenure Track Assistant Professor & Group Leader
Medical University of Graz
Florence APPARAILLY
INSERM
Evelyn Gaffal
University Hospital Magdeburg
Stephan Blüml
Medical University of Vienna
Jacqueline D. Shields
-
Raffaele Nicastro
University of Fribourg
Rostyslav Bilyy
-
Anika Rajput Khokhar
Charité - Universitätsmedizin Berlin
Jason Turner
University of Birmingham
Tobias Bäuerle
Professor
University of Erlangen-Nuremberg
Christoph Magnes
Head of Research Group
Joanneum Research
Michael Bonelli
Medical University of Vienna
Make your next move.
Prepare your application
Review drafts before you send them.